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Oxidative stress and inflammation are implicated in the initiation and development of 
obesity and diabetes .This study investigated the comparison of important oxidative 
stress parameters between diabetic and obese patients and it is significantly (p < 0.05) 
showed that the level of oxidative stress is more in obese. Level of Hs-CRP also has 
been increased in the obese patients. It is revealed that oxidative stress has a main role 
in this disease. 
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Oxidative damage has been implicated in the 
pathogenesis of many chronic progressive 
diseases, such as inflammation, and 
neurodegenerative disorders. Over the last 
decade, there has been considerable interest 
in the role of oxidative stress in vascular 
disease as well. This interest has been driven 
by a affluence of data indicating that LDL1 
oxidation is a prominent feature of 
atherosclerosis .More recently, studies have 
also suggested that oxidative stress is a 
feature of many risk factors for premature 
atherosclerosis, such as diabetes,2 and 
obesity. Obesity is an established risk factor 
for many diseases like diabetes, CVD and 
metabolic syndrome3.Oxidative stress can be 
a consequence and also a trigger for obesity4 
.The inefficient scavenging of ROS in diabetes 
may countribute toincreased oxidative 
damage. The mechanism of impaired 
antioxidant defense in DM is poorly 
understood. Non enzymatic glycation of 
antioxidant enzymes with a consequent loss of 
activity may be one of the causes5. In this 
study we investigate to compare the level of 
oxidative stress parameters in diabetic and 
obese patients. 
 
MATERIALS AND METHODS 
 
DPPH was purchased from Sigma Chemical 
Company, USA. Ascorbic acid and BHT were 
purchased from SR Laboratories, Mumbai, 
India. All other chemicals, solvents and 
reagents were purchased from local suppliers 
and the chemicals were of highest purity. The 
study protocol was approved by the ethical 
committee of Mysore University, India and the 
consent was taken from all of the subjects. 
The weight of 20 subjects  were recorded by a 
weight machine  with accuracy of + 100 gm, 
models  KRPUS (New Delhi, India) and 
standing height measured without shoes to 
the nearest 0.5 centimeter with use of 
commercial meter, with the shoulders in 
relaxed position and arms hanging freely. 
Body mass index (BMI) calculated by weight 
(kg) divided by height in meter square (m2). 
Blood was drawn by vein puncture at the 
Biochem Diagnostic and Research Lab. 
Whole blood was used for blood glucose 
estimation immediately. The remaining blood 
was allowed to clot.  The serum was 
separated by centrifugation and used for 
assay of High Sensitive C-Reactive Protein 
(Hs-CRP), total antioxidant capacity and 
DPPH radical scavenging activity.  
 
Phosphomolybdate method 
The total antioxidant capacity of the fractions 
was determined by phosphomolybdate 
method using vitamin E as the standard6. An 
aliquot of 0.1ml of the fractions (100 µg) 
solution was combined with 1.0 ml of reagent 
(0.6 M sulfuric acid, 28 mM sodium phosphate 
and 4 mM ammonium molybdate). The tubes 
were capped and incubated in a boiling water 
bath at 95oC for 90 min. After the samples 
had cooled to room temperature, the 
absorbance was measured at 695 nm against 
the blank using an UV spectrophotometer. 
The blank solution contained 1.0 ml of reagent 
solution and the appropriate volume of the 
same solvent used for the sample and it was 
incubated under the same conditions as rest 
of the sample. The total antioxidant capacity 
was expressed as µg equivalents of vitamin E 
by using the standard vitamin E graph. 
 
Determination of lipid peroxidation 
Lipid oxidation in lipoproteins was assessed 
by spectrophotometric monitoring of 
conjugated diene formation, according to the 
method of 7 with slight modification. Briefly, 
serum (5ul) was diluted with phosphate 
buffered saline (PBS, 995µl) (5 mM phosphate 
buffer, 125mM NaCl, pH 7.4). LDL and HDL 
were diluted 1:50 with PBS. 100 µl of diluted 
serum sample, LDL or HDL was mixed with 
850µl PBS and 50µl of 5µM copper sulfate 
(CuSo4). The OD of the mixture was 
monitored at 234 nm every 10 min for up to 90 
min. The optical density was plotted against 
time.  
 
Estimation of serum C-reactive protein 
(CRP) 
 With the ultra sensitive C-reactive protein 
Latex test Kit (Acros organics, Bangalore, 
India), latex particles coated with antibody 
specific to CRP aggregate in the presence of 
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CRP in the sample, forming immune 
complexes. The immune complexes cause an 
increase in light scattering, which is 
proportional to the concentration of CRP in the 
sample. The light scattering is measured by 
reading turbidity at 550 nm. 
Statistical analysis 
Results are expressed as mean + SD. Means 






The fasting and post prandial blood glucose of the Diabetic subjects is shown in 
 
 
The mean blood glucose level was 140±30.2 mg/dl. The range was 103.7 to 176.8 mg/dl. The mean post prandial blood was 270.8±50.1 
mg/dl and the range was 200 to 338 mg/dl. The BMI of the obese subjects was 32.82 + 2.73. 
 
Figure 2 
Comparison of antioxidant capacity of diabetic and obese patients in 
 
 
The antioxidant capacity of the serum of diabetics was 20.4±2.8 µg. ascorbic acid for 10µl serum. For the same amount of serum the 
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Figure 3 
The DPPH radical scavenging activity of BHT is shown in 
 
 
                     With increasing concentration of DHT there was a linear increase in the DPPH radical scavenging activity. 
 
Figure 4 
The DPPH radical scavenging activity of serum from diabetic  
and obese subjects are shown in 
 
 
The DPPH radical scavenging activity of 10µl of serum of diabetics was equivalent to 40.5± 21.3 µg of BHT. Whereas the radical 
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Figure 5 
Serum lipoprotein oxidation of obese and diabetic subjects is  
shown in and compared with control subjects. 
 
 
 Initially there was a 4 fold increase in the presence of 234 nm absorbing substances in the serum of diabetic as well as obese subjects. 
Upon oxidation with cu++ ions, the 234 nm absorption increased with time for the control subjects. Where for both the diabetic and obese 
subjects, there was an initial increase followed by a decrease in the absorption at 234 nm. There was no significant difference between 
the diabetic and obese subjects. (P >0.05). 
 
Figure 6 
The Hs-CRP of obese subjects is shown in 
 
 
                          The mean Hs CRP level was 7.12±5.64 mg/lt. From the graph of ranges of Hs CRP,  




Antioxidant is defined depending on the 
circumstances, generally they are defined as 
substances that oppose or prevent the action 
of oxidants. However this definition is 
appropriate for an in vitro reaction of an 
antioxidant. But in a biological or in vivo 
situation this definition is modified as a 
substance that opposes the damaging effect 
of an oxidant8. There are many physiologically 
relevant mechanisms that generate oxidants 
and free radicals. For example, mitochondria 
produce free radicals and superoxide9. During 
the flow of electrons in the respiratory chain a 
small percent of the electrons (1-3%) “Leak” to 
oxygen forming superoxide10. Peroxisomes 
consume a large portion of the oxygen of the 
cell for metabolic reactions involving oxygen. 
For their normal metabolism, they produce 
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H2O2. However peroxisomes also have 
catalase and hence it does not allow the 
accumulation of H2O2. Phagocytic cells like 
macrophages produce superoxide through 
their respiratory burst oxidase to destroy 
bacterial infection 11. Myeloperoxidase is 
another enzyme of the phagocytic cells used 
to kill pathogens.  Myeloperoxidase produces 
Hypochlorous acid which is a potent pro-
oxidant12. The endoplasmic reticulum also 
produces reactive oxygen species because it 
has NADPH- cytP450 reductase enzyme used 
in metabolism of Xenobiotic13. The plasma 
membrane contains enzymes like 
lipoxygenases and cyclooxygenases which 
generate biologically active oxidized lipids 
during the biosynthesis of prostaglandins 
thromboxanes, Leukotrienes and HETEs. In 
addition to these, diet, air, atmosphere and 
environment can also generate reactive 
oxygen species and free radicals. Free radical 
generation and scavenging as well as 
production of oxidation and their neutralization 
by antioxidants are regulated processes useful 
for the organism to survive. However during 
some pathological circumstances the pro-
oxidants exceed the antioxidant defense 
system. This is the underlying cause of many 
disorders like diabetes cardiovascular 
diseases, cancer and obesity. The antioxidant 
capacity of the plasma or serum represents 
the total antioxidant molecules that can 
produce antioxidant defense to the organism. 
In our study, we found that the total 
antioxidant capacity of serum of diabetics was 
significantly lower than that of the obese 
subjects (P<00005). This suggests that 
diabetics have a higher oxidative stress when 
compared with obese subjects. DPPH is a 
stable Nitrogen centered free radical which 
can be scavenged by antioxidant present in 
the serum. In our study the DPPH radical 
scavenging activity was lower in diabetic 
serum compared with serum from obese 
subjects. These results are in agreement with 
the reduced antioxidant capacity in diabetics 
compared with obese subjects. Lipoprotein 
oxidation is the key step in the initiation of 
atherosclerosis. Lipoproteins like LDL and 
HDL are both subject to oxidative modification. 
When HDL is oxidized, it loses its 
atheroprotective function and becomes a 
proatherogenic molecule.  The serum of 
diabetics as well as obese subjects appeared 
to have been oxidized since the 234 nm 
absorbing substances were higher than the 
control subjects. The lipoprotein oxidation 
profile of control serum shows these distinct 
phases of oxidation, namely the lag phase, log 
phase and the stationary phase. Whereas, the 
serum of diabetics as well as obese subjects 
showed only the decline phase of oxidation, in 
this phase, the oxidation products of lipids 
breakdown and react with the protein part of 
the lipoprotein. In both diabetes and obesity 
these appears to be oxidative stress    
resulting in the higher oxidation of lipoprotein. 
In our study we found all the obese subjects 
having moderate to high CRP levels 
suggesting that the obese subjects were in a 




Our study showed that the diabetics had lower 
antioxidant capacity and DPPH radical 
scavenging activity than obese subjects. The 
lipoprotein oxidation of both diabetic serum 
and obese serum was comparable. The obese 
subjects had moderate to high levels of C - 
reactive protein, an acute phase protein in this 
serum.  
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